<DOC>
	<DOCNO>NCT01872221</DOCNO>
	<brief_summary>This prospective biomedical study interventional type include 16 patient 52 month ( 24 month inclusion 28 month follow ) . This pilot study , combine metabolic image approach ( Proton Magnetic Resonance Spectroscopy = 1HMRSI ) biological one , perform patient harbour Glioblastoma ( GBM ) determine whether MRI marker aggressiveness ( CNI2 ) associate specific biological pattern regard GBMSC ( GBM contain tumor stem cell ) . In first part study , patient radiological criterion GBM amenable surgical resection include ; pre-operative multimodal MRI scan do data acquire ( include H1MRS DTI data ) integrate image-guided surgical device ( ie neuronavigation system ) use intraoperatively . During tumor resection , tissue sample individualize , base multimodal image characteristic send radiobiology laboratory INSERM biological analysis . After surgery , patient treat standard radio-chemotherapy stupp protocol follow accord standard practice ; multimodal MRI perform every 2 month first year every 3 month progression .</brief_summary>
	<brief_title>Study Capacity MRI Spectroscopy Define Tumor Area Enriched Glioblastoma Stem Cells . Proof Concept Study</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>First part study ( Surgery Imagery ) : 1 . Surgical indication patient present radiological criterion glioblastoma . 2 . Patient ≥18 year old 3 . Patient must performance status 0 2 ECOG Performance Scale 4 . Life expectancy ≥ 3 month 5 . Patient affiliate social security regimen 6 . Patient voluntarily agree participate give write informed consent first part study . Second part study ( Treatment Biology ) : 1 . Histologically confirm glioblastoma 2 . Patient must performance status 0 2 ECOG Performance Scale 3 due motor deficit . 3 . Life expectancy ≥ 3 month 4 . Patient affiliate social security regimen 5 . Patient voluntarily agree participate give write informed consent second part study . First part study ( Surgery Imagery ) : 1 . Patients allow perform MRI 2 . Spectroscopic exam whose result contributive 3 . Pregnant nursing patient , 4 . Patients law protection 5 . Patient present condition would interfere cooperation requirement trial . 6 . Patient present medical , severe chronic biological psychiatric condition allow enrolment study , accord investigator 's opinion Second part study ( Treatment Biology ) : 1.Biological material receive lab 48 hour surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Glioblastoma</keyword>
	<keyword>Spectroscopy</keyword>
	<keyword>MRI</keyword>
	<keyword>Glioma stem cell</keyword>
	<keyword>Surgery</keyword>
	<keyword>Radioresistance</keyword>
</DOC>